LBX Pharmacy Chain JSC
SSE:603883
LBX Pharmacy Chain JSC
Operating Income
LBX Pharmacy Chain JSC
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
LBX Pharmacy Chain JSC
SSE:603883
|
Operating Income
¥1.6B
|
CAGR 3-Years
16%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
Operating Income
¥2B
|
CAGR 3-Years
14%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
Yunnan Jianzhijia Health-Chain Co Ltd
SSE:605266
|
Operating Income
¥542.1m
|
CAGR 3-Years
34%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
Operating Income
¥2.2B
|
CAGR 3-Years
24%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
ShuYu Civilian Pharmacy Corp Ltd
SZSE:301017
|
Operating Income
¥384m
|
CAGR 3-Years
38%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
|
Operating Income
¥1.4B
|
CAGR 3-Years
16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
See Also
What is LBX Pharmacy Chain JSC's Operating Income?
Operating Income
1.6B
CNY
Based on the financial report for Sep 30, 2023, LBX Pharmacy Chain JSC's Operating Income amounts to 1.6B CNY.
What is LBX Pharmacy Chain JSC's Operating Income growth rate?
Operating Income CAGR 5Y
20%
Over the last year, the Operating Income growth was 28%. The average annual Operating Income growth rates for LBX Pharmacy Chain JSC have been 16% over the past three years , 20% over the past five years .